162 related articles for article (PubMed ID: 1951863)
1. Successful immunization of humans with irradiated malaria sporozoites: humoral and cellular responses of the protected individuals.
Herrington D; Davis J; Nardin E; Beier M; Cortese J; Eddy H; Losonsky G; Hollingdale M; Sztein M; Levine M
Am J Trop Med Hyg; 1991 Nov; 45(5):539-47. PubMed ID: 1951863
[TBL] [Abstract][Full Text] [Related]
2. Humoral immune responses in volunteers immunized with irradiated Plasmodium falciparum sporozoites.
Egan JE; Hoffman SL; Haynes JD; Sadoff JC; Schneider I; Grau GE; Hollingdale MR; Ballou WR; Gordon DM
Am J Trop Med Hyg; 1993 Aug; 49(2):166-73. PubMed ID: 8357078
[TBL] [Abstract][Full Text] [Related]
3. Characterization of immunoglobulin G antibodies to Plasmodium falciparum sporozoite surface antigen MB2 in malaria exposed individuals.
Nguyen TV; Sacci JB; de la Vega P; John CC; James AA; Kang AS
Malar J; 2009 Oct; 8():235. PubMed ID: 19852802
[TBL] [Abstract][Full Text] [Related]
4. Long-term persistence of sterile immunity in a volunteer immunized with X-irradiated Plasmodium falciparum sporozoites.
Edelman R; Hoffman SL; Davis JR; Beier M; Sztein MB; Losonsky G; Herrington DA; Eddy HA; Hollingdale MR; Gordon DM
J Infect Dis; 1993 Oct; 168(4):1066-70. PubMed ID: 8376823
[TBL] [Abstract][Full Text] [Related]
5. Plasmodium falciparum sporozoite immunization protects against Plasmodium berghei sporozoite infection.
Sina BJ; do Rosario VE; Woollett G; Sakhuja K; Hollingdale MR
Exp Parasitol; 1993 Sep; 77(2):129-35. PubMed ID: 8375482
[TBL] [Abstract][Full Text] [Related]
6. Cellular and humoral immune responses to a recombinant P. falciparum CS protein in sporozoite-immunized rodents and human volunteers.
Nardin EH; Nussenzweig RS; Altszuler R; Herrington D; Levine M; Murphy J; Davis J; Bathurst I; Barr P; Romero P
Bull World Health Organ; 1990; 68 Suppl(Suppl):85-7. PubMed ID: 2094595
[TBL] [Abstract][Full Text] [Related]
7. Safety, immunogenicity, and efficacy of a Plasmodium falciparum vaccine comprising a circumsporozoite protein repeat region peptide conjugated to Pseudomonas aeruginosa toxin A.
Fries LF; Gordon DM; Schneider I; Beier JC; Long GW; Gross M; Que JU; Cryz SJ; Sadoff JC
Infect Immun; 1992 May; 60(5):1834-9. PubMed ID: 1563771
[TBL] [Abstract][Full Text] [Related]
8. Protection against malaria after immunization by chloroquine prophylaxis and sporozoites is mediated by preerythrocytic immunity.
Bijker EM; Bastiaens GJ; Teirlinck AC; van Gemert GJ; Graumans W; van de Vegte-Bolmer M; Siebelink-Stoter R; Arens T; Teelen K; Nahrendorf W; Remarque EJ; Roeffen W; Jansens A; Zimmerman D; Vos M; van Schaijk BC; Wiersma J; van der Ven AJ; de Mast Q; van Lieshout L; Verweij JJ; Hermsen CC; Scholzen A; Sauerwein RW
Proc Natl Acad Sci U S A; 2013 May; 110(19):7862-7. PubMed ID: 23599283
[TBL] [Abstract][Full Text] [Related]
9. Mosquito bite immunization with radiation-attenuated Plasmodium falciparum sporozoites: safety, tolerability, protective efficacy and humoral immunogenicity.
Hickey BW; Lumsden JM; Reyes S; Sedegah M; Hollingdale MR; Freilich DA; Luke TC; Charoenvit Y; Goh LM; Berzins MP; Bebris L; Sacci JB; De La Vega P; Wang R; Ganeshan H; Abot EN; Carucci DJ; Doolan DL; Brice GT; Kumar A; Aguiar J; Nutman TB; Leitman SF; Hoffman SL; Epstein JE; Richie TL
Malar J; 2016 Jul; 15(1):377. PubMed ID: 27448805
[TBL] [Abstract][Full Text] [Related]
10. Safety, immunogenicity, and pilot efficacy of Plasmodium falciparum sporozoite and asexual blood-stage combination vaccine in Swiss adults.
Sturchler D; Berger R; Rudin C; Just M; Saul A; Rzepczyk C; Brown G; Anders R; Coppel R; Woodrow G
Am J Trop Med Hyg; 1995 Oct; 53(4):423-31. PubMed ID: 7485698
[TBL] [Abstract][Full Text] [Related]
11. Recognition of different domains of the Plasmodium falciparum CS protein by the sera of naturally infected individuals compared with those of sporozoite-immunized volunteers.
Calle JM; Nardin EH; Clavijo P; Boudin C; Stüber D; Takacs B; Nussenzweig RS; Cochrane AH
J Immunol; 1992 Oct; 149(8):2695-701. PubMed ID: 1401909
[TBL] [Abstract][Full Text] [Related]
12. Recombinant Liver Stage Antigen-1 (LSA-1) formulated with AS01 or AS02 is safe, elicits high titer antibody and induces IFN-gamma/IL-2 CD4+ T cells but does not protect against experimental Plasmodium falciparum infection.
Cummings JF; Spring MD; Schwenk RJ; Ockenhouse CF; Kester KE; Polhemus ME; Walsh DS; Yoon IK; Prosperi C; Juompan LY; Lanar DE; Krzych U; Hall BT; Ware LA; Stewart VA; Williams J; Dowler M; Nielsen RK; Hillier CJ; Giersing BK; Dubovsky F; Malkin E; Tucker K; Dubois MC; Cohen JD; Ballou WR; Heppner DG
Vaccine; 2010 Jul; 28(31):5135-44. PubMed ID: 19737527
[TBL] [Abstract][Full Text] [Related]
13. Down-selecting circumsporozoite protein-based malaria vaccine: A comparison of malaria sporozoite challenge model.
Amelia F; Iyori M; Emran TB; Yamamoto DS; Genshi K; Otsuka H; Onoue Y; Yusuf Y; Islam A; Yoshida S
Parasite Immunol; 2019 May; 41(5):e12624. PubMed ID: 30883819
[TBL] [Abstract][Full Text] [Related]
14. Human studies with synthetic peptide sporozoite vaccine (NANP)3-TT and immunization with irradiated sporozoites.
Herrington DA; Clyde DF; Davis JR; Baqar S; Murphy JR; Cortese JF; Bank RS; Nardin E; DiJohn D; Nussenzweig RS
Bull World Health Organ; 1990; 68 Suppl(Suppl):33-7. PubMed ID: 2094588
[TBL] [Abstract][Full Text] [Related]
15. Modest heterologous protection after Plasmodium falciparum sporozoite immunization: a double-blind randomized controlled clinical trial.
Walk J; Reuling IJ; Behet MC; Meerstein-Kessel L; Graumans W; van Gemert GJ; Siebelink-Stoter R; van de Vegte-Bolmer M; Janssen T; Teelen K; de Wilt JHW; de Mast Q; van der Ven AJ; Diez Benavente E; Campino S; Clark TG; Huynen MA; Hermsen CC; Bijker EM; Scholzen A; Sauerwein RW
BMC Med; 2017 Sep; 15(1):168. PubMed ID: 28903777
[TBL] [Abstract][Full Text] [Related]
16. Irradiated sporozoite vaccine induces HLA-B8-restricted cytotoxic T lymphocyte responses against two overlapping epitopes of the Plasmodium falciparum sporozoite surface protein 2.
Wizel B; Houghten RA; Parker KC; Coligan JE; Church P; Gordon DM; Ballou WR; Hoffman SL
J Exp Med; 1995 Nov; 182(5):1435-45. PubMed ID: 7595214
[TBL] [Abstract][Full Text] [Related]
17. Detection of CD4+CD45RO+ T lymphocytes producing IL-4 in response to antigens on Plasmodium falciparum erythrocytes: an in vitro correlate of protective immunity induced with attenuated Plasmodium falciparum sporozoites.
Bergmann ES; Ballou RW; Krzych U
Cell Immunol; 1997 Sep; 180(2):143-52. PubMed ID: 9341744
[TBL] [Abstract][Full Text] [Related]
18. Long-term protection against malaria after experimental sporozoite inoculation: an open-label follow-up study.
Roestenberg M; Teirlinck AC; McCall MB; Teelen K; Makamdop KN; Wiersma J; Arens T; Beckers P; van Gemert G; van de Vegte-Bolmer M; van der Ven AJ; Luty AJ; Hermsen CC; Sauerwein RW
Lancet; 2011 May; 377(9779):1770-6. PubMed ID: 21514658
[TBL] [Abstract][Full Text] [Related]
19. In vitro immune recognition of synthetic peptides from the Plasmodium falciparum CS protein by individuals naturally exposed to different sporozoite challenge.
Esposito F; Lombardi S; Modiano D; Habluetzel A; Del Nero L; Lamizana L; Pietra V; Rotigliano G; Corradin G; Ravot E
Immunol Lett; 1992 Jul; 33(2):187-99. PubMed ID: 1446925
[TBL] [Abstract][Full Text] [Related]
20. Heterologous Protection against Malaria after Immunization with Plasmodium falciparum Sporozoites.
Schats R; Bijker EM; van Gemert GJ; Graumans W; van de Vegte-Bolmer M; van Lieshout L; Haks MC; Hermsen CC; Scholzen A; Visser LG; Sauerwein RW
PLoS One; 2015; 10(5):e0124243. PubMed ID: 25933168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
